SAT-770 Pathogenic Variant Analysis of ZFX in Sporadic Parathyroid Adenomas

Abstract Disclosure: S. Halili: None. L. Iommazzo: None. C. Burke: None. J. Bellizzi: None. J. Costa-Guda: None. A. Arnold: None. Primary hyperparathyroidism (PHPT) is a common disorder defined by PTH oversecretion and calcium dysregulation. Most cases are caused by parathyroid adenomas, with smaller proportions attributed to multigland hyperplasia and carcinoma. In addition to established genetic drivers like CCND1, MEN1, and CDC73, several candidate genes have been implicated in parathyroid adenoma development. Of particular interest is ZFX, which encodes a conserved zinc-finger transcription factor known to play a role in tumor development and stem cell renewal. We first linked ZFX to PHPT when specific, recurring somatic missense variants in adjacent arginine residues in critical zinc finger domain 13 (codons 786 and 787) were identified in a subset of parathyroid adenomas. Recently, germline missense ZFX variants (in zinc finger domains 12 and 13) were identified in 11 probands with an X-linked neurodevelopmental disorder, and 3 of the 7 probands for whom data were available had PHPT. Several neurodevelopmentally unaffected female carriers of these variants also had PHPT requiring parathyroidectomy. Additionally, a separate case report described a female patient with learning disability and a parathyroid adenoma, who carried a similar heterozygous germline ZFX variant R764W. These strong links between PHPT and missense variants within the crucial DNA-binding region of ZFX carry potentially important clinical and mechanistic implications. To further investigate the role of ZFX variants in causing or contributing to PHPT, we performed Sanger sequencing of zinc finger domains 12 and 13 of ZFX in 231 sporadic parathyroid adenoma DNA samples. Three variants, one in each of three tumors, were identified and interestingly, each was represented in the highly restricted set of codons previously implicated. One male-derived adenoma had the R787T variant, with indeterminate germline/somatic status. One female-derived adenoma was heterozygous for R764W and was somatic, in contrast to its previously reported role as a germline variant. Further, the identical heterozygous R764W was identified in an additional female-derived sample (germline/somatic status currently not determined). These findings suggest that domain 12/13 ZFX missense variants are relatively rare in otherwise typically presenting sporadic parathyroid adenomas. Our results also reinforce the emerging concept in parathyroid neoplasia that these exquisitely specific variants appear to be strongly pathogenic when present, whether as germline predisposition alleles or as somatically mutated tumor drivers, and their downstream mechanistic consequences in parathyroid cells merit investigation. Presentation: Saturday, July 12, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.624
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SAT-770 Pathogenic Variant Analysis of ZFX in Sporadic Parathyroid Adenomas

Justin Bellizzi, Jessica Costa‐Guda, Andrew Arnold, Callie Burke et al.
Journal of the Endocrine Society
Parathyroid Disorders and Treatments
article

SAT-770 Pathogenic Variant Analysis of ZFX in Sporadic Parathyroid Adenomas

Justin Bellizzi, Jessica Costa‐Guda, Andrew Arnold, Callie Burke, Sara Halili, Lucas Iommazzo
article en

Abstract

Abstract Disclosure: S. Halili: None. L. Iommazzo: None. C. Burke: None. J. Bellizzi: None. J. Costa-Guda: None. A. Arnold: None. Primary hyperparathyroidism (PHPT) is a common disorder defined by PTH oversecretion and calcium dysregulation. Most cases are caused by parathyroid adenomas, with smaller proportions attributed to multigland hyperplasia and carcinoma. In addition to established genetic drivers like CCND1, MEN1, and CDC73, several candidate genes have been implicated in parathyroid adenoma development. Of particular interest is ZFX, which encodes a conserved zinc-finger transcription factor known to play a role in tumor development and stem cell renewal. We first linked ZFX to PHPT when specific, recurring somatic missense variants in adjacent arginine residues in critical zinc finger domain 13 (codons 786 and 787) were identified in a subset of parathyroid adenomas. Recently, germline missense ZFX variants (in zinc finger domains 12 and 13) were identified in 11 probands with an X-linked neurodevelopmental disorder, and 3 of the 7 probands for whom data were available had PHPT. Several neurodevelopmentally unaffected female carriers of these variants also had PHPT requiring parathyroidectomy. Additionally, a separate case report described a female patient with learning disability and a parathyroid adenoma, who carried a similar heterozygous germline ZFX variant R764W. These strong links between PHPT and missense variants within the crucial DNA-binding region of ZFX carry potentially important clinical and mechanistic implications. To further investigate the role of ZFX variants in causing or contributing to PHPT, we performed Sanger sequencing of zinc finger domains 12 and 13 of ZFX in 231 sporadic parathyroid adenoma DNA samples. Three variants, one in each of three tumors, were identified and interestingly, each was represented in the highly restricted set of codons previously implicated. One male-derived adenoma had the R787T variant, with indeterminate germline/somatic status. One female-derived adenoma was heterozygous for R764W and was somatic, in contrast to its previously reported role as a germline variant. Further, the identical heterozygous R764W was identified in an additional female-derived sample (germline/somatic status currently not determined). These findings suggest that domain 12/13 ZFX missense variants are relatively rare in otherwise typically presenting sporadic parathyroid adenomas. Our results also reinforce the emerging concept in parathyroid neoplasia that these exquisitely specific variants appear to be strongly pathogenic when present, whether as germline predisposition alleles or as somatically mutated tumor drivers, and their downstream mechanistic consequences in parathyroid cells merit investigation. Presentation: Saturday, July 12, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
University of Connecticut (US), UConn Health (US)
Openalex Percentile: Top 66%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.